Original language | English |
---|---|
Pages (from-to) | 297-298 |
Number of pages | 2 |
Journal | The Lancet |
Volume | 398 |
Issue number | 10297 |
Early online date | 7 Jul 2021 |
DOIs | |
Publication status | Published - 24 Jul 2021 |
Keywords
- Mass infection
- Herd immunity
- Vaccination
- COVID-19
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: The Lancet, Vol. 398, No. 10297, 24.07.2021, p. 297-298.
Research output: Contribution to journal › Letter
}
TY - JOUR
T1 - Mass infection is not an option
T2 - We must do more to protect our young
AU - Gurdasani, Deepti
AU - Drury, John
AU - Greenhalgh, Trisha
AU - Griffin, Stephen
AU - Haque, Zubaida
AU - Hyde, Zoë
AU - Katzourakis, Aris
AU - McKee, Martin
AU - Michie, Susan
AU - Pagel, Christina
AU - Reicher, Stephen D.
AU - Roberts, Alice
AU - West, Robert
AU - Yates, Kit
AU - Ziauddeen, Hisham
N1 - Funding Information: JD, ZHa, MM, SM, CP, AR, and SR are members of Independent SAGE. SR is a member of the advisory group to the Scottish Chief Medical Officer. RW, SM, SR, and JD are participants in the Independent Scientific Pandemic Insights Group on Behaviours, the behavioural science subgroup of SAGE. JD declares funding for research on public behaviour in the pandemic, paid to the University of Sussex, from the Economic and Social Research Council (ESRC) and fees from the BBC and The Guardian for media appearances and articles. SG declares research grants from the Medical Research Council (MRC) and the AMMF and fees from Hallmark Care Homes for webinars about vaccine hesitancy. SG is also a member of the UK Government's COVID-19 Expert Panel on Home Testing and the COVID-19 International Best Practice Advisory Group, and he is a consultant on shielding for the International Comparators Joint Unit (IBPAG-ICJU). SG is Chair of the Virus Division of the Microbiology Society and a member of the British Society for Antimicrobial Chemotherapy grants review panel. SM declares research grants from the MRC, the ESRC, the Wellcome Trust, Cancer Research UK, and the National Institutes of Health Research and fees from the BBC and ITN for media appearances. All other authors declare no competing interests. A summit to discuss the concerns outlined in this Correspondence will take place on July 8, 2021. Signatories of this Correspondence are listed in the appendix .
PY - 2021/7/24
Y1 - 2021/7/24
KW - Mass infection
KW - Herd immunity
KW - Vaccination
KW - COVID-19
UR - http://www.scopus.com/inward/record.url?scp=85111051682&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(21)01589-0
DO - 10.1016/S0140-6736(21)01589-0
M3 - Letter
SN - 0140-6736
VL - 398
SP - 297
EP - 298
JO - The Lancet
JF - The Lancet
IS - 10297
ER -